Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
International Journal of Molecular Sciences|June 19, 2024
An Overview of Epigenetic Changes in the Parkinson's Disease BrainAnthony Klokkaris, Anna Migdalska-RichardsJournal of Neurochemistry|February 11, 2016
The relationship between glucocerebrosidase mutations and Parkinson diseaseAnna Migdalska-Richards, Anthony H V SchapiraMedycyna Wieku Rozwojowego|October 10, 2006
[Attention deficit hyperactivity disorder (ADHD)--molecular and genetic aspects]Anna Migdalska, Magdalena Nawara, Jerzy Bal, et al.Annals of Neurology|November 19, 2016
Ambroxol effects in glucocerebrosidase and α-synuclein transgenic miceAnna Migdalska-Richards, Liam Daly, Erwan Bezard, et al.Synapse (New York, N.Y.)|March 16, 2017
Oral ambroxol increases brain glucocerebrosidase activity in a nonhuman primateAnna Migdalska-Richards, Wai Kin D Ko, Qin Li, et al.International Journal of Molecular Sciences|February 11, 2023
DNA Methylation of α-Synuclein Intron 1 Is Significantly Decreased in the Frontal Cortex of Parkinson's Individuals with GBA1 MutationsAdam R Smith, David M Richards, Katie Lunnon, et al.Human Molecular Genetics|July 6, 2016
Autophagic lysosome reformation dysfunction in glucocerebrosidase deficient cells: relevance to Parkinson diseaseJoana Magalhaes, Matthew E Gegg, Anna Migdalska-Richards, et al.Plos One|August 25, 2020
L444P Gba1 mutation increases formation and spread of α-synuclein deposits in mice injected with mouse α-synuclein pre-formed fibrilsAnna Migdalska-Richards, Michal Wegrzynowicz, Ian F Harrison, et al.Brain : a Journal of Neurology|October 4, 2017
The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in miceAnna Migdalska-Richards, Michal Wegrzynowicz, Raffaella Rusconi, et al.Pageof 1